Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05041309
Title Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells
Recruitment Enrolling by invitation
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kite, A Gilead Company
Indications

hematologic cancer

Advanced Solid Tumor

Therapies

KITE-585

KITE-222

Brexucabtagene autoleucel

KITE-718

axicabtagene ciloleucel

KITE-439

Age Groups: senior | child | adult
Covered Countries USA


No variant requirements are available.